CARTER BRUCE L A

Director at RENOVIS INC · on record since Jan 18, 2006
Director at ZYMOGENETICS INC · on record since Mar 15, 2006
Director at NOVELION THERAPEUTICS INC. · on record since Dec 1, 2006
Director at Regulus Therapeutics Inc. · on record since Nov 8, 2012
President & CEO at ZYMOGENETICS INC · on record since Jan 9, 2004
Director at ENANTA PHARMACEUTICALS INC · on record since Dec 6, 2013
Director at Xencor Inc · on record since Dec 2, 2013
Director at Mirati Therapeutics, Inc. · on record since Sep 29, 2016
Director at ALSP Orchid Acquisition Corp I · on record since Nov 18, 2021

Insider trading activity of CARTER BRUCE L A

Transactions on record: 170; since Jan 9, 2004

Open-market buys: 3; $339.7K

Open-market sells: 51; $9.5M

Companies traded: 7; last filing Mar 13, 2026

Figures computed from official regulatory filings — .

Companies where CARTER BRUCE L A has traded

ENANTA PHARMACEUTICALS INC28 tx · $1.6M · Mar 13, 2026
Mirati Therapeutics, Inc.64 tx · $4.8M · Jan 23, 2024
Xencor Inc17 tx · $1.1M · Jun 16, 2017
Regulus Therapeutics Inc.9 tx · $448.8K · Jun 26, 2015
NOVELION THERAPEUTICS INC.7 tx · $41.4K · May 27, 2011
ZYMOGENETICS INC41 tx · $9.8M · Oct 12, 2010
4 tx · May 7, 2008

Track record of CARTER BRUCE L A

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of CARTER BRUCE L A

Co-insiders of CARTER BRUCE L A

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ENANTA PHARMACEUTICALS INCListing on record	Mar 13, 2026	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 14, 2025	AwardD (derivative)	15,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 8, 2024	AwardD (derivative)	15,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	Other	-6,808	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	Other	-4,444	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	OtherD (derivative)	-7,520	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	OtherD (derivative)	-11,000	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	Other	-6,021	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 3, 2024	Award	6,808	58.75 USD	$400K		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 6, 2023	AwardD (derivative)	10,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 24, 2023	Award	4,444	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 24, 2023	AwardD (derivative)	7,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Aug 16, 2022	Sell	-5,107	85.04 USD	$434.3K	Unusual size	SEC
Mirati Therapeutics, Inc.Listing unverified	Aug 16, 2022	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Aug 16, 2022	Exercise	10,000	27.00 USD	$270K	Unusual size	SEC
Mirati Therapeutics, Inc.Listing unverified	Aug 16, 2022	Sell	-4,893	85.96 USD	$420.6K	Unusual size	SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	Sell	-2,210	68.66 USD	$151.7K		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	Exercise	6,000	25.58 USD	$153.5K	Unusual size	SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	ExerciseD (derivative)	-6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	Sell	-2,676	66.70 USD	$178.5K		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	Sell	-307	67.23 USD	$20.6K		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	Sell	-807	69.52 USD	$56.1K		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 7, 2022	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 18, 2022	AwardD (derivative)	3,688	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ENANTA PHARMACEUTICALS INCListing on record	Mar 13, 2026	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 14, 2025	AwardD (derivative)	15,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 8, 2024	AwardD (derivative)	15,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	Other	-6,808	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	Other	-4,444	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	OtherD (derivative)	-7,520	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	OtherD (derivative)	-11,000	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 23, 2024	Other	-6,021	—	n/a (No price was disclosed in the filing)		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 3, 2024	Award	6,808	58.75 USD	$400K		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 6, 2023	AwardD (derivative)	10,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 24, 2023	Award	4,444	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 24, 2023	AwardD (derivative)	7,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Aug 16, 2022	Sell	-5,107	85.04 USD	$434.3K	Unusual size	SEC
Mirati Therapeutics, Inc.Listing unverified	Aug 16, 2022	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Aug 16, 2022	Exercise	10,000	27.00 USD	$270K	Unusual size	SEC
Mirati Therapeutics, Inc.Listing unverified	Aug 16, 2022	Sell	-4,893	85.96 USD	$420.6K	Unusual size	SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	Sell	-2,210	68.66 USD	$151.7K		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	Exercise	6,000	25.58 USD	$153.5K	Unusual size	SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	ExerciseD (derivative)	-6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	Sell	-2,676	66.70 USD	$178.5K		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	Sell	-307	67.23 USD	$20.6K		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 22, 2022	Sell	-807	69.52 USD	$56.1K		SEC
ENANTA PHARMACEUTICALS INCListing on record	Mar 7, 2022	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirati Therapeutics, Inc.Listing unverified	Jan 18, 2022	AwardD (derivative)	3,688	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC